{"id":140,"date":"2015-10-04T01:32:00","date_gmt":"2015-10-04T01:32:00","guid":{"rendered":"https:\/\/cfedsc.org\/?p=140"},"modified":"2023-03-23T14:39:59","modified_gmt":"2023-03-23T14:39:59","slug":"a-phase-2-multicenter-randomized-double-blind-placebo-controlled-parallel-group-study-to-evaluate-the-efficacy-safety-and-tolerability-of-ctx-4430-administered-orally-once-daily-for-48-weeks-in","status":"publish","type":"post","link":"https:\/\/cfedsc.org\/?p=140","title":{"rendered":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\">A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis<\/h1>\n","protected":false},"excerpt":{"rendered":"<p>A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[11],"class_list":["post-140","post","type-post","status-publish","format-standard","hentry","category-clinical-trial-reports","tag-clinical-trial-reports"],"_links":{"self":[{"href":"https:\/\/cfedsc.org\/index.php?rest_route=\/wp\/v2\/posts\/140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cfedsc.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cfedsc.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cfedsc.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cfedsc.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=140"}],"version-history":[{"count":0,"href":"https:\/\/cfedsc.org\/index.php?rest_route=\/wp\/v2\/posts\/140\/revisions"}],"wp:attachment":[{"href":"https:\/\/cfedsc.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cfedsc.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cfedsc.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}